Drugs.com: Escitalopram reduces symptoms of anxiety in teens
Outlet covers UC research that points to a possible new treatment for adolescent anxiety
For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.
Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.
"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.
Read the full Drugs.com story.
Psych Central also reported on this research.
Read the full UC News release.
Featured photo courtesy of Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.
Three years, countless stories
May 15, 2026
UC's Klekamp Law celebrates its 193rd Hooding with stories from graduates reflecting on their paths through the college.
A jolly good trip: Bearcats take on London for fragrance company
May 15, 2026
Six NEXT Innovation Scholars at the University of Cincinnati traveled to London to transform field research into actionable recommendations for British luxury bath, body and fragrance brand Molton Brown.